M. Shelley

2.2k total citations · 1 hit paper
17 papers, 1.7k citations indexed

About

M. Shelley is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, M. Shelley has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in M. Shelley's work include Asthma and respiratory diseases (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Pediatric health and respiratory diseases (4 papers). M. Shelley is often cited by papers focused on Asthma and respiratory diseases (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Pediatric health and respiratory diseases (4 papers). M. Shelley collaborates with scholars based in United Kingdom and Canada. M. Shelley's co-authors include Ian Pavord, Christopher E. Brightling, Beverley Hargadon, Andrew J. Wardlaw, Dominick Shaw, Debbie Parker, Ruth H. Green, Peter Bradding, Mike Berry and Susan McKenna and has published in prestigious journals such as New England Journal of Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

M. Shelley

15 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma

2006 631 citations Mike Berry, Beverley Hargadon et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by M. Shelley

Since Specialization

Citations

This map shows the geographic impact of M. Shelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Shelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Shelley more than expected).

Fields of papers citing papers by M. Shelley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Shelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Shelley. The network helps show where M. Shelley may publish in the future.

Co-authorship network of co-authors of M. Shelley

This figure shows the co-authorship network connecting the top 25 collaborators of M. Shelley. A scholar is included among the top collaborators of M. Shelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Shelley. M. Shelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Myeloid-derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in chronic obstructive pulmonary disease 2016 ·Allergy ·Adam Wright, Chris Newby, Ruth Hartley, Vijay Mistry, Sumit Gupta, Rachid Berair, Katy M. Roach, Ruth Saunders, (unknown), M. Shelley, (unknown), Bethan Barker, Christopher E. Brightling	13
2	Physical activity heterogeneity in COPD; meaningful analysis of data 2016 ·Chris Newby, (unknown), Bethan Barker, M. Shelley, (unknown), Leena George, Linzy Houchen‐Wolloff, Christopher E. Brightling, Sally Singh	1
3	Toll-like receptor 9 dependent interferon-α release is impaired in severe asthma but is not associated with exacerbation frequency 2015 ·Immunobiology ·Adam Wright, Vijay Mistry, Matthew Richardson, M. Shelley, (unknown), Sarah Terry, Bethan Barker, Mona Bafadhel, Christopher E. Brightling	8
4	Mutually exclusive Th2 and Th17 bronchial gene expression signatures are associated with eosinophilia in asthma 2014 ·European Respiratory Journal ·David F. Choy, Aarti Shikotra, Salman Siddiqui, Deepti R. Nagarkar, Alexander R. Abbas, Chandra Ohri, Emma Doran, Claire A. Butler, Beverley Hargadon, M. Shelley, Lawren C. Wu, Liam G. Heaney, Joseph R. Arron, Peter Bradding	4
5	Associations between quantitative CT measures and airway inflammation in COPD 2013 ·European Respiratory Journal ·Bethan Barker, Ruth Hartley, (unknown), M. Shelley, (unknown), Mitesh Pancholi, Nisha Rana, Mini Pakkal, Sumit Gupta, Mona Bafadhel, Christopher E. Brightling	1
6	Quantitative CT in COPD MAP: Emphysema and small airways disease independently contribute to FEV1 2013 ·Ruth Hartley, Bethan Barker, (unknown), J Finch, M. Shelley, (unknown), Mini Pakkal, Mona Bafadhel, Sumit Gupta, Christopher E. Brightling	1
7	Increased expression of immunoreactive thymic stromal lymphopoetin in severe asthma 2012 ·Journal of Allergy and Clinical Immunology ·A Shikotra, David F. Choy, Chandra Ohri, Emma Doran, (unknown), Beverley Hargadon, M. Shelley, Alexander R. Abbas, Cary D. Austin, Janet Jackman, Lidan Wu, Liam G. Heaney, Joseph R. Arron, Peter Bradding	0
8	A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma 2012 ·Primary Care Respiratory Journal ·Dominick Shaw, Ruth Green, Mike Berry, (unknown), Beverley Hargadon, M. Shelley, (unknown), Mike Thomas, Ian Pavord	33
9	Can We Identify Asthma Patients Who Can Safely Reduce Their Inhaled Corticosteroid Medication Without Suffering From A Loss Of Control? 2012 ·Emma Wilson, B. Hargadon, M. Shelley, Glenn Hearson, Rebecca Simms, Helen D. Bailey, David Hodgson, John Anderson, Tricia M. McKeever, Mike Thomas, Ian Pavord, Tim Harrison, Dominick Shaw	0
10	Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma 2011 ·Journal of Allergy and Clinical Immunology ·Aarti Shikotra, David F. Choy, Chandra Ohri, Emma Doran, Claire A. Butler, Beverley Hargadon, M. Shelley, Alexander R. Abbas, Cary D. Austin, Janet Jackman, Lawren C. Wu, Liam G. Heaney, Joseph R. Arron, Peter Bradding	257
11	S44 Increased expression of immunoreactive thymic stromal lymphopoetin in severe asthma 2010 ·Thorax ·A Shikotra, Beverley Hargadon, M. Shelley, Jonathan Bennett, Christopher E. Brightling, Cary D. Austin, David F. Choy, Lawren C. Wu, Joseph R. Arron, Peter Bradding	1
12	P122 The use of impulse oscillometry (IOS) to study fractal scaling and sample entropy in airway resistance time series in severe asthma 2010 ·Thorax ·(unknown), Dhananjay Desai, (unknown), M. Shelley, Amisha Singapuri, Christopher E. Brightling, Salman Siddiqui	2
13	P17 Self-reported physical activity levels and attitudes towards a structured exercise programme in adults with difficult asthma 2010 ·Thorax ·Amisha Singapuri, (unknown), B. Hargadon, M. Shelley, Dhananjay Desai, (unknown), Christopher E. Brightling, Ian Pavord, Peter Bradding, Andrew J. Wardlaw, (unknown)	1
14	Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial 2007 ·European Respiratory Journal ·Roshan Siva, (unknown), Christopher E. Brightling, M. Shelley, Beverley Hargadon, Susan McKenna, William Monteiro, M A Berry, Debbie Parker, Andrew J. Wardlaw, Ian Pavord	343
15	Association Between Neutrophilic Airway Inflammation and Airflow Limitation in Adults With Asthma 2007 ·CHEST Journal ·Dominick Shaw, Michael A. Berry, B. Hargadon, Susan McKenna, M. Shelley, Ruth H. Green, Christopher E. Brightling, Andrew J. Wardlaw, Ian Pavord	181
16	Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma breakdown → 2006 ·New England Journal of Medicine ·Mike Berry, Beverley Hargadon, M. Shelley, Debbie Parker, Dominick Shaw, Ruth H. Green, Peter Bradding, Christopher E. Brightling, Andrew J. Wardlaw, Ian Pavord	631
17	Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma 2005 ·European Respiratory Journal ·M A Berry, Beverley Hargadon, Angela Morgan, M. Shelley, Joachim Richter, Dominick Shaw, (unknown), Christopher E. Brightling, Andrew J. Wardlaw, Ian Pavord	175

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact